Role of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localization
© Heibein et al.; licensee BioMed Central Ltd. 2012
Received: 19 January 2012
Accepted: 17 August 2012
Published: 31 August 2012
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|19 Jan 2012||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|10 Mar 2012||Reviewed||Reviewer Report - Martin Clynes|
|22 Mar 2012||Reviewed||Reviewer Report - Elaina Collie-Duguid|
|24 May 2012||Author responded||Author comments - Amadeo Parissenti|
|Resubmission - Version 3|
|24 May 2012||Submitted||Manuscript version 3|
|18 Jul 2012||Reviewed||Reviewer Report - Elaina Collie-Duguid|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|17 Aug 2012||Editorially accepted|
|31 Aug 2012||Article published||10.1186/1471-2407-12-381|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.